Amphastar Pharma (AMPH) Tops Q3 EPS by 11c

Amphastar Pharma (NASDAQ: AMPH) reported Q3 EPS of $0.14, $0.11 better than the analyst estimate of $0.03. Revenue for the quarter came in at $64.2 million versus the consensus estimate of $65.12 million.

For earnings history and earnings-related data on Amphastar Pharma (AMPH) click here.

You May Also Be Interested In

• ManpowerGroup (MAN) Tops Q2 EPS by 4c; offers guidance
• UnitedHealth rallies premarket while chip stocks retreat; TSMC earnings lift A
• Commerce Bancshares (CBSH) Tops Q2 EPS by 4c, Beats on Revenue